VIDEO: New laser offers further improvement to laser scleral microporation
Click Here to Manage Email Alerts
BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, AnnMarie Hipsley, DPT, PhD, and George O. Waring IV, MD, FACS, discuss the latest advances in laser scleral microporation.
Hipsley said that the GenII VisioLite laser for laser scleral microporation (LSM) is on the pathway to commercialization and may be available by the end of the year.
“We are very excited about this treatment especially because it brings something totally new to the presbyopia game,” Hipsley said.
LSM is an ultra-minimally invasive procedure that can be used during the early stages of presbyopia. It is a therapeutic approach rather than a correction for what Hipsley called dysfunctional lens syndrome.
“When we think about the 2 billion presbyopes worldwide ... there is an incredible unmet need for presbyopia treatment,” Waring said. “[LSM] is going to fit a segment of the market we currently do not have an option for.”
Collapse
Healio Interviews
Read more about
Click Here to Manage Email Alerts